As for the more feasible S-NFL, a reasonable correlation with CSF-NFL and an ability to reflect disease activity in MS [15, 29, 30] was here confirmed, reiterating the suggestion of S-NFL as a promising biomarker. The gene discussed is NEFL; the disease is myeloid sarcoma.